We utilized the CRISPR/Cas9 system to integrate a CAR expression cassette into the CCR5 locus, thereby achieving simultaneous CAR integration and CCR5 disruption, rendering the HIV-specific CAR T cells resistant to HIV infection. Here, CCR5 is linked to HIV infectious disease.